Atlas Trials

Hyperpolarized 13C MRI for Cancer Immunotherapy

Clinical trial NCT05805358 · UNKNOWN

Trial details

NCT number
NCT05805358
Sponsor
Chang Gung Memorial Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gynecologic CancerCervical CancerEndometrial CancerOvarian Cancer
Start date
2023-11-01
Primary completion
2026-07-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.